{"id":791078,"date":"2024-11-27T07:12:59","date_gmt":"2024-11-27T12:12:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/"},"modified":"2024-11-27T07:12:59","modified_gmt":"2024-11-27T12:12:59","slug":"ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/","title":{"rendered":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference"},"content":{"rendered":"
\n

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen will present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th<\/sup> Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL\u2014taking place December 3 – 4, 2024.<\/p>\n

\u201cEvery year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,\u201d said Dr. Musunuri. \u201cI look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.\u201d<\/p>\n

Details regarding the presentation and moderated Q&A are as follows:<\/p>\n

\n Date:\u00a0<\/strong>Tuesday, December 3, 2024<\/p>\n

\n Location:<\/strong>\u00a0Presentation Room 3<\/p>\n

\n Time:<\/strong>\u00a01:30 p.m. ET\u00a0\u00a0<\/p>\n

In addition to Dr. Musunuri\u2019s session, members of Ocugen\u2019s executive team will conduct one-on-one meetings with investors to highlight the Company\u2019s business and clinical development strategy across its unique modifier gene therapy platform.<\/p>\n

A high-definition video webcast of the presentation will be available the following day in the\u00a0Events<\/a>\u00a0section of the Company\u2019s website, and as part of a complete catalog of presentations available at Noble Capital Markets\u2019 Conference website<\/a>\u00a0and on Channelchek<\/a>\u00a0the investor portal created by Noble. The webcast will be archived on the Company’s website, the NobleCon website, and Channelchek.com for 90 days following the event.\u00a0<\/p>\n

\n About Ocugen, Inc.<\/strong>\u00a0
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients\u2019 lives through courageous innovation\u2014forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at\u00a0www.ocugen.com<\/a>\u00a0and follow us on\u00a0X<\/a>\u00a0and\u00a0LinkedIn<\/a>.<\/p>\n

\n About Noble Capital Markets, Inc.\u00a0<\/strong>
\n
Established in 1984, Noble Capital Markets is an SEC \/ FINRA registered full-service investment bank and advisory firm with an award-winning research team and proprietary investor distribution platform.\u00a0We deliver middle market expertise to entrepreneurs, corporations, financial sponsors, and investors. Over the past 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports. Noble launched\u00a0www.channelchek.com<\/a>\u00a0in 2018 – an investor community dedicated exclusively to public emerging growth and their industries. Channelchek is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 7,000 public emerging growth companies are listed on the site, and content including equity research, webcasts, and industry articles.<\/p>\n

\n Cautionary Note on Forward-Looking Statements<\/strong>
\n
****This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d estimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled \u201cRisk Factors\u201d in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.<\/p>\n

\n Contact:<\/strong>
\n
Tiffany Hamilton
Head of Communications
Tiffany.Hamilton@ocugen.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen will present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL\u2014taking place December 3 – 4, 2024. \u201cEvery year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,\u201d said Dr. Musunuri. \u201cI look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.\u201d Details … <\/p>\n

Continue reading “Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-791078","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOcugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen will present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL\u2014taking place December 3 – 4, 2024. \u201cEvery year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,\u201d said Dr. Musunuri. \u201cI look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.\u201d Details … Continue reading "Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-27T12:12:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference\",\"datePublished\":\"2024-11-27T12:12:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/\"},\"wordCount\":686,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/\",\"name\":\"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=\",\"datePublished\":\"2024-11-27T12:12:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk","og_description":"MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen will present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL\u2014taking place December 3 – 4, 2024. \u201cEvery year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,\u201d said Dr. Musunuri. \u201cI look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.\u201d Details … Continue reading \"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-11-27T12:12:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference","datePublished":"2024-11-27T12:12:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/"},"wordCount":686,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/","name":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=","datePublished":"2024-11-27T12:12:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MDg2OCM2NjEyMjU2IzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-ceo-to-present-at-noblecon20-noble-capital-markets-20th-annual-emerging-growth-equity-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen CEO to Present at NobleCon20 \u2013 Noble Capital Markets\u2019 20th Annual Emerging Growth Equity Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=791078"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=791078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=791078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=791078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}